
Kidney Medicine
@KidneyMed
Followers
10K
Following
717
Media
1K
Statuses
2K
Kidney Medicine | Official Journal of @NKF | #NSMC Collaborator | #OpenAccess
Joined October 2018
Kidney Outcomes in Patients With Advanced Heart Failure Treated With Ventricular Assist Devices (VADS) .
kidneymedicinejournal.org
Ventricular assist devices (VADs) are used for advanced heart failure, but their impact on kidney function remains unclear. This study evaluated changes in kidney function following VAD implantation,...
0
3
9
Primary Care Physicians’ Perspective on SGLT2 Inhibitors for Chronic Kidney Disease .
kidneymedicinejournal.org
Singapore has the second-highest per capita prevalence of chronic kidney disease (CKD) in the world (11.4%).1 Sodium/glucose cotransporter 2 inhibitors (SGLT2is) have shown significant efficacy at...
0
2
11
Hemoadsorption as a Supportive Strategy for Severe Toxicity Associated With Chimeric Antigen Receptor T Cell Therapy: A Case Series .
kidneymedicinejournal.org
To describe the use and effects of extracorporeal blood purification with hemoadsorption in managing severe complications after treatment with chimeric antigen receptor T-cells (CAR-T).
0
1
3
Effect of Post-acute Kidney Injury Use of Renin-Angiotensin Inhibitors on Long-term Mortality and Major Adverse Kidney Events: A 5-year Retrospective Observational Cohort Study .
kidneymedicinejournal.org
Acute kidney injury (AKI) is common in hospitalized adults and a risk factor for chronic kidney disease and mortality. The effect of angiotensin-converting enzyme inhibitors (ACEi) or angiotensin...
0
2
11
Acute Kidney Injury Secondary to Pegylated Liposomal Doxorubicin-Associated Renal-limited Thrombotic Microangiopathy .
kidneymedicinejournal.org
The emergence of pegylated liposomal doxorubicin (PLD) as a preferred treatment for various malignancies, because of its reduced cardiotoxicity compared with conventional doxorubicin, has raised...
0
6
14
Vascular Access Thrombosis Events in Patients With Dialysis-Dependent Chronic Kidney Disease Treated With Vadadustat or Darbepoetin Alfa: The INNO2VATE Trial Program .
kidneymedicinejournal.org
In the global phase 3 INNO2VATE program of patients with dialysis-dependent chronic kidney disease (DD-CKD) and CKD-related anemia (2 trials: patients new to [NCT02865850] and established on mainte...
0
1
3
Effect of a Population Health Management Intervention on Medication Therapy Problems in People With Chronic Kidney Disease: Post Hoc Analysis of the K-CHAMP Cluster-Randomized Trial .
kidneymedicinejournal.org
Medication therapy problems (MTPs) are therapeutic issues related to medications that may cause undesirable events. People with chronic kidney disease (CKD) are at high risk of experiencing MTPs...
0
1
2
Genetic Testing in Biopsy-Confirmed Kidney Disease .
kidneymedicinejournal.org
Disease-causing genetic variants are identified in approximately 10%-20% of adult patients with chronic kidney disease (CKD).1-3 Identification of genetic variants can confirm diagnosis, inform...
0
4
18
Evaluation of Light Chain Removal Rates in Blood Purification Therapy for Light Chain Cast Nephropathy .
kidneymedicinejournal.org
Acute kidney injury is a crucial prognostic factor for multiple myeloma. The most common cause is light chain cast nephropathy. The primary pathology of light chain-induced acute kidney injury...
0
2
12
CKD Knowledge and CKD Report Card Use During a Nephrology Encounter: A Randomized Trial .
kidneymedicinejournal.org
Higher chronic kidney disease (CKD) knowledge and health literacy (HL) are associated with improved CKD outcomes. We sought to determine if the CKD Report Card intervention increased CKD knowledge in...
0
3
4